幼年系统性硬化症管理的共识建议
针对罕见病幼年系统性硬化症(JSSc),SHARE 倡议基于专家意见和现有最佳证据制定评估与治疗推荐,强调除皮肤外还需关注内脏受累早期征象,并提出疾病严重度评分和阶梯治疗策略以改善长期结局。
要点
- 推荐对JSSc进行结构化评估,除皮肤外重点识别内脏受累早期征象。
- 提出疾病严重度评分用于纵向评估结局,但需在更广泛人群中验证。
- 建议采用阶梯治疗策略以统一欧洲诊疗标准,降低病死率。
核心结论
- SHARE倡议基于专家意见和现有最佳证据,为幼年系统性硬化症的评估与治疗提供共识推荐,以改善患者结局。
研究设计与样本
- 本推荐为SHARE(欧洲儿科风湿病单一枢纽与接入点)倡议制定的共识建议,基于专家意见并参考现有最佳证据。
主要发现
- 专家关注不仅限于皮肤评估,还包括内脏受累的早期征象,其恰当治疗可显著影响长期结局。
- 提出疾病严重度评分以进行结构化结局评估,但建议在更广泛患者人群中验证。
- 提出阶梯治疗策略以统一欧洲诊疗标准,旨在降低该病患病率和死亡率。
关键数值与推荐
- 提出疾病严重度评分用于结构化评估结局,但需在更广泛患者人群中验证。
- 提出阶梯治疗策略以统一欧洲诊疗标准。
临床怎么用
- 临床中应对JSSc患者进行结构化评估,除皮肤外重点筛查内脏受累早期征象并及时治疗。
- 可参考所提疾病严重度评分进行纵向结局评估,但需注意其尚待更广泛人群验证。
- 治疗上可遵循所提阶梯治疗策略,以统一诊疗标准并致力于降低患病率和死亡率。
局限性
- 推荐基于专家意见和现有最佳证据,疾病严重度评分需在更广泛患者人群中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Juvenile systemic sclerosis (JSSc) is a rare disease of childhood and currently no international consensus exists with regard to its assessment and treatment. This SHARE (Single Hub and Access point for paediatric Rheumatology in Europe) initiative, based on expert opinion informed by the best available evidence, provides recommendations for the assessment and treatment of patients with JSSc with a view to improving their outcome. Experts focused attention not only on the skin assessment but also on the early signs of internal organ involvement whose proper treatment can significantly affect the long-term outcome. A score for disease severity is proposed in order to perform a structured assessment of outcome over time but a validation in a wider patient population is recommended. Finally, a stepwise treatment approach is proposed in order to unify the standard of care throughout Europe with the aim to reduce morbidity and mortality in this disease.
引用
- Foeldvari I, Culpo R, Sperotto F, et al. Consensus-based recommendations for the management of juvenile systemic sclerosis. Rheumatology (Oxford). 2021. PMID: 33147624. doi:10.1093/rheumatology/keaa584
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。